382 related articles for article (PubMed ID: 14639580)
1. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.
Figarella-Branger D; Civatte M; Bartoli C; Pellissier JF
Muscle Nerve; 2003 Dec; 28(6):659-82. PubMed ID: 14639580
[TBL] [Abstract][Full Text] [Related]
2. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
3. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.
De Paepe B; Creus KK; De Bleecker JL
Ann N Y Acad Sci; 2007 Aug; 1109():441-53. PubMed ID: 17785333
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms in inflammatory myopathies.
Hohlfeld R; Goebels N; Engel AG
Baillieres Clin Neurol; 1993 Nov; 2(3):617-35. PubMed ID: 8156145
[TBL] [Abstract][Full Text] [Related]
5. Update on idiopathic inflammatory myopathies.
Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
[TBL] [Abstract][Full Text] [Related]
6. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
De Paepe B; Creus KK; De Bleecker JL
Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
[TBL] [Abstract][Full Text] [Related]
7. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies.
Dehmel T; Janke A; Hartung HP; Goebel HH; Wiendl H; Kieseier BC
Neurobiol Dis; 2007 Mar; 25(3):665-74. PubMed ID: 17207628
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approaches in patients with inflammatory myopathies.
Dalakas MC
Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and dendritic cells in inflammatory myopathies.
Tournadre A; Miossec P
Ann Rheum Dis; 2009 Mar; 68(3):300-4. PubMed ID: 19213746
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic targets for idiopathic inflammatory myopathies.
De Bleecker JL; Creus KK; De Paepe B
Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
Raju R; Dalakas MC
Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
[TBL] [Abstract][Full Text] [Related]
13. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
14. Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies.
Schleinitz N; Cognet C; Guia S; Laugier-Anfossi F; Baratin M; Pouget J; Pelissier JF; Harle JR; Vivier E; Figarella-Branger D
Arthritis Rheum; 2008 Oct; 58(10):3216-23. PubMed ID: 18821690
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
Dalakas MC
Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
[TBL] [Abstract][Full Text] [Related]
16. Immune effector mechanisms in inflammatory myopathies.
Engel AG; Arahata K; Emslie-Smith A
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():141-57. PubMed ID: 2158132
[TBL] [Abstract][Full Text] [Related]
17. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
18. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
Dalakas MC
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
[TBL] [Abstract][Full Text] [Related]
19. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
20. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.
Lundberg IE
Curr Rheumatol Rep; 2000 Jun; 2(3):216-24. PubMed ID: 11123062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
